Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor

European Journal of Pharmacology

Volumn 758, Issue , 2015, Pages 16-23

  Abate, Carmen ^a   Niso, Mauro ^a   Infantino, Vittoria ^b   Menga, Alessio ^a   Berardi, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF BASILICATA   (Italy)

Author keywords

PGRMC1 protein; 2 receptor; 2 receptoragonists

Indexed keywords

F 395; F 397; F 408; OPIATE AGONIST; PB 221; PB 28; PENTAZOCINE; PGRMC1 PROTEIN; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PROTEIN; PROTEIN INHIBITOR; PROTEINASE INHIBITOR; RADIOLIGAND; SIGMA 2 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR AGONIST; SIRAMESINE; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PGRMC1 PROTEIN, HUMAN; PROGESTERONE RECEPTOR; SIGMA OPIATE RECEPTOR;

ADENOCARCINOMA CELL LINE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER DIAGNOSIS; CANCER THERAPY; CONTROLLED STUDY; DRUG TARGETING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCATCHARD PLOT; WESTERN BLOTTING; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; GENETIC TRANSFECTION; GUINEA PIG; METABOLISM; RADIOASSAY; RAT;

ANIMALS; CELL SURVIVAL; GENE SILENCING; GUINEA PIGS; HUMANS; MCF-7 CELLS; MEMBRANE PROTEINS; RADIOLIGAND ASSAY; RATS; RECEPTORS, PROGESTERONE; RECEPTORS, SIGMA; TRANSFECTION;

EID: 84927556019     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.03.067     Document Type: Article

References (33)

1. 2B dimer ChemMedChem 5 2010 268 273
2. 2 receptor antagonists ChemMedChem 7 2012 1847 1857
3. C. Abate, M. Niso, M. Contino, N.A. Colabufo, S. Ferorelli, R. Perrone, and F. Berardi 1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: mixed σ and human Δ(8)-Δ(7) sterol isomerase ligands with antiproliferative and P-glycoprotein inhibitory activity ChemMedChem 6 2011 73 80
4. 2) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activity Curr. Pharm. Des 18 2012 938 949
5. I.S. Ahmed, C. Chamberlain, and R.J. Craven S2R (Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling Expert Opin. Drug Metab. Toxicol. 8 2012 361 370
6. I. Al-Nabulsi, R.H. Mach, L.M. Wang, C.A. Wallen, P.C. Keng, K. Sten, S.R. Childers, and K.T. Wheeler Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells Br. J. Cancer 81 1999 925 933
7. 1 antagonist receptor inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer Mol. Cancer Ther. 5 2006 1807 1816
8. ®) J. Biol. Chem. 289 2014 32353 32363 10.1074/jbc.M114.603506
9. 2 receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) J. Med. Chem. 52 2009 7817 7828
10. 18F]ISO-1 (FISO PET/CT).
11. E.J. Cobos, J.M. Entrena, F.R. Nieto, C.M. Cendan, and E. Del Pozo Pharmacology and therapeutic potential of sigma1 receptor ligands Curr. Neuropharmacol. 6 2008 344 366
12. 2 receptor a histone binding protein? J. Med. Chem. 49 2006 4153 4158
13. M. Hanner, F.F. Moebius, A. Flandorfer, H.G. Knaus, J. Striessnig, E. Kempner, and H. Glossmann Purification, molecular cloning, and expression of the mammalian sigma1-binding site Proc. Natl. Acad. Sci. USA 93 1996 8072 8077
14. 1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export J. Pharmacol. Exp. Ther. 306 2003 718 725
15. J.R. Hornick, S. Vangveravong, D. Spitzer, C. Abate, F. Berardi, P. Goedegebuure, R.H. Mach, and W.G. Hawkins Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer J. Exp. Clin. Cancer Res. 31 2012 41
16. J.R. Hornick, J. Xu, S. Vangveravong, Z. Tu, J.B. Mitchem, D. Spitzer, P. Goedegebuure, R.H. Mach, and W.G. Hawkins The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine Mol. Cancer 9 2010 298
17. V. Infantino, P. Convertini, A. Menga, and V. Iacobazzi MEF2C exon α: role in gene activation and differentiation Gene 531 2 2013 355 362
18. N.J. Izzo, A. Staniszewski, L. To, M. Fa, A.F. Teich, F. Saeed, H. Wostein, T. Walko III, A. Vaswani, M. Wardius, Z. Syed, J. Ravenscroft, K. Mozzoni, C. Silky, C. Rehak, R. Yurko, P. Finn, G. Look, G. Rishton, H. Safferstein, M. Miller, C. Johanson, E. Stopa, M. Windisch, B. Hutter-Paier, M. Shamloo, O. Arancio, H. LeVine III, and S.M. Catalano Alzheimers therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits PLoS One 9 2014 e111898
19. N.J. Izzo, J. Xu, C. Zeng, M.J. Kirk, K. Mozzoni, C. Silky, C. Rehak, R. Yurko, G. Look, G. Rishton, H. Safferstein, C. Cruchaga, A. Goate, M.A. Cahill, O. Arancio, R.H. Mach, R. Craven, E. Head, H. LeVine III, T.L. Spires-Jones, and S.M. Catalano Alzheimers therapeutics targeting amyloid beta 1-42 oligomers II: sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity PLoS One 9 2014 e111899
20. S. Kourrich, T. Hayashi, J.Y. Chuang, S.Y. Tsai, T.P. Su, and A. Bonci Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine Cell 152 2013 236 247
21. R.H. Mach, C.R. Smith, I. Al-Nabulsi, B.R. Whirrett, S.R. Childers, and K.T. Wheeler Sigma-2 receptors as potential biomarkers of proliferation in breast cancer Cancer Res. 57 1997 156 161
22. R.R. Matsumoto, W.D. Bowen, M.A. Tom, D.D. Truong, and B.R. De Costa Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism Eur. J. Pharmacol. 280 1995 301 310
23. V. Megalizzi, M. Le Mercier, and C. Decaestecker Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy Med. Res. Rev. 32 2012 410 427
24. S.U. Mir, I.S. Ahmed, S. Arnold, and R.J. Craven Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients Int. J. Cancer 131 2012 E1 9
25. S.U. Mir, S.R. Schwarze, L. Jin, J. Zhang, W. Friend, S. Miriyala St, D. Clair, and R.J. Craven Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy Autophagy 9 2013 1566 1578
26. M. Niso, C. Abate, M. Contino, S. Ferorelli, A. Azzariti, R. Perrone, N.A. Colabufo, and F. Berardi Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity ChemMedChem 8 2013 2026 2035
27. Prism Software Version 3.0 for Windows 1998 GraphPad Software, Inc. San Diego, CA
28. A.E. Ruoho, L.W. Guo, A.R. Hajipour, K. Karaoglu, T.A. Mavlyutov, U.B. Chu, and J. Yang Will the true sigma-2 receptor please stand up? San Diego Neuroscience 2013
29. A. van Waarde, A.A. Rybczynska, N.K. Ramakrishnan, K. Ishiwata, P.H. Elsinga, and R.A. Dierckx Potential applications for sigma receptor ligands in cancer diagnosis and therapy S0005-2736(14)00304-6 Biochim. Biophys. Acta 2014 10.1016/j.bbamem.2014.08.022
30. B.J. Vilner, C.S. John, and W.D. Bowen Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines Cancer Res. 55 1995 408 413
31. K.T. Wheeler, L.M. Wang, C.A. Wallen, S.R. Childers, J.M. Cline, P.C. Keng, and R.H. Mach Sigma-2 receptors as a biomarker of proliferation in solid tumours Br. J. Cancer 82 2000 1223 1232
32. J. Xu, C. Zeng, W. Chu, F. Pan, J.M. Rothfuss, F. Zhang, Z. Tu, D. Zhou, D. Zeng, S. Vangveravong, F. Johnston, D. Spitzer, K.C. Chang, R.S. Hotchkiss, W.G. Hawkins, K.T. Wheeler, and R.H. Mach Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site Nat. Commun. 2 2011 380
33. C. Zeng, J. Rothfuss, J. Zhang, W. Chu, S. Vangveravong, Z. Tu, F. Pan, K.C. Chang, R. Hotchkiss, and R.H. Mach Sigma-2 ligands induce tumour cell death by multiple signalling pathways Br. J. Cancer 106 2012 693 701